Pharmabiz6h
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...
Pharmabiz9h
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa: Our Bureau, Mumbai ...
Pharmabiz3h
Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension
Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz4h
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner: Manila, Philippines Friday, January 10, 2025, 17:00 Hrs [IST] Zuellig Pharma, a leading healthcare solu ...
Pharmabiz7h
Dr Sunita Tandulwadkar takes over as 63rd FOGSI president, unveils bold vision for transforming women’s healthcare in India
Our Bureau, Mumbai Friday, January 10, 2025, 14:45 Hrs [IST] ...
Pharmabiz5h
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial: Potomac, Maryland Friday, January 10, 2025, 16:30 Hrs [IST] IGC Pharma, Inc, an AI-powe ...
Pharmabiz6h
Medi Assist’s 2024 findings shed light on rising costs, incidence and demography wise hospitalisation patterns
Our Bureau, Mumbai Friday, January 10, 2025, 15:40 Hrs [IST] ...
Pharmabiz6h
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...
Pharmabiz5h
Impose 5-15% duty on imports of medical devices and monitor MRP against import landed cost, demands AiMeD
Our Bureau, New Delhi Friday, January 10, 2025, 16:10 Hrs [IST] ...
Pharmabiz6h
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...
Pharmabiz4d
Eton Pharma acquires Galzin, an US FDA approved treatment of ultra-rare metabolic condition of Wilson disease
Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired Galzin (zinc acetate). “This ...
Pharmabiz7h
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...